"Most of the work required to bring a drug to market is knowledge work. But drug development is the knowledge work equivalent of a rocket launch... There’s been little efficiency and reusability of common processes and components. 

The promise of AI is that it enables the reusability and efficiency of software to extend beyond current bounds into work that requires human expertise today: clinical trial design, site selection and operations, competitive intelligence, sales and marketing, etc" - Alex Telford

Exciting to see how AI is revolutionizing drug development by enhancing efficiency and reusability in processes that require human expertise. This innovation has the potential to transform various aspects of the healthcare industry and improve patient outcomes. 